Discover the latest 3D in vitro tools for metabolic disease modeling
Meet InSphero Chief Scientific Officer Dr. Patrick Guye at the Keystone Symposium on Organ Crosstak in Obesity and NAFLD (J3), held in conjunction this year with the meeting on Bioenergetics and Metabolic Disease (J4). Dr. Guye will be available throughout the meeting to discuss the latest advances in 3D in vitro models for studying metabolic diseases such as:
- Diet-induced Steatosis, Fibrosis, and NASH
- Type 1 and Type 2 Diabetes
Diseased human 3D microtissues as building blocks for complex metabolic in vitro systems
Dr. Guye will present work using a new generation of screening-compatible 3D microtissue models that emulate the healthy and various diseased states of human liver and pancreatic islets, adaptable to a unique standard multi-well microtissue plate format and novel microphysiological system (MPS) to accommodate interconnected culture and assay of such microtissues.